Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Facial Flushing
NCT02216838Phase 4Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2014
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A (2 arms), sponsored by Northwestern University. Primary endpoint: Spectrophotometer measurement at 8 weeks. Started Aug 2014; status: active, not recruiting.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on NCT02216838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216838.